<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Krishna Kumar Tiwari</submitter><journal>Clinical and translational science</journal><pagination>343-349</pagination><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/MODEL2009230001</full_dataset_link><repository>biostudies-other</repository><additional_accession>30990958</additional_accession><pubmed_authors>Krishna Kumar Tiwari</pubmed_authors><pubmed_authors>Tung Nguyen</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hardiansyah2019 - QSP model of chimeric antigen receptor T-Cell therapy</name><description>&lt;notes xmlns="http://www.sbml.org/sbml/level2/version4">    &lt;body xmlns="http://www.w3.org/1999/xhtml">     &lt;p>This QSP model explains how the mechanism of action connects to the clinical outcomes and, therefore, may serve as an important model-based platform to guide the development and personalized dosing of the CART therapy.&lt;/p>    &lt;/body>    &lt;/notes></description><dates><release>2020-09-23T00:00:00Z</release><modification>2025-07-14T17:42:10.161Z</modification><creation>2025-03-30T22:53:46.939Z</creation></dates><accession>MODEL2009230001</accession><cross_references><pubmed>30990958</pubmed><ncit>C15262</ncit><ncit>C16974</ncit><mamo>MAMO_0000046</mamo><taxonomy>9606</taxonomy></cross_references></HashMap>